Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00424008Phase 3Completed
Phase 3, randomised, single-blind trial of mometasone furoate + formoterol fumarate in asthma (2 arms), sponsored by Organon & Co. Primary endpoint: Area Under the Curve From 0 to 12 Hours of the Change From Baseline in Forced Expiratory Volume in One Second. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00424008.